Aktie A1J8HD SICHUAN HEBANG BIOTECHNOLOGY CORPORATION LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sichuan Hebang Biotechnology Corporation Limited

Aktien

A1J8HD

CNE100001JM9

603077

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 30.04.2024 		% 5 Tage % 1. Jan.
2,1 CNY -2,33 % Intraday Chart für Sichuan Hebang Biotechnology Corporation Limited -1,41 % -11,02 %
19.04. Sichuan Hebang Biotechnology Corporation Limited meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
21.02. Stellvertretender Vorsitzender von Yapp Automotive Parts legt sein Amt nieder MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sichuan Hebang Biotechnology Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on January 25, 2024.
Yapp Automotive Parts Vice Chairman Resigns
Chinese provinces target modest 2024 growth after missing previous goals
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on December 15, 2023.
Sichuan Hebang Biotechnology Corporation Limited announces an Equity Buyback for CNY 400 million worth of its shares.
Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback announced on December 15, 2023, has closed with 168,811,563 shares, representing 1.93% for CNY 389.79 million.
Sichuan Hebang Biotechnology Corporation Limited authorizes a Buyback Plan.
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on December 15, 2023.
Sichuan Hebang Biotechnology Corporation Limited announces an Equity Buyback for CNY 400 million worth of its shares.
Tranche Update on Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback Plan announced on October 19, 2023.
Sichuan Hebang Biotechnology Corporation Limited authorizes a Buyback Plan.
Sichuan Hebang Biotechnology Corporation Limited's Equity Buyback announced on October 19, 2023, has closed with 170,337,200 shares, representing 1.95% for CNY 399.89 million.
Avenira Limited announced that it has received AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation Limited
Sichuan Hebang Biotechnology Corporation Limited(SHSE:603077) dropped from Shanghai Stock Exchange 180 Value Index
Sichuan Hebang Biotechnology Corporation Limited(SHSE:603077) dropped from SSE 180 Index
Hebang Biotechnology to Buy 10.5% Stake in Australia-Listed Avenira For AU$2 Million
Avenira Limited announced that it expects to receive AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation Limited
Sichuan Salt Industry Corporation and Sichuan Salt Industry Group West Sichuan Co., Ltd. agreed to acquire 49% stake in Sichuan Shuncheng Salt Products Co., Ltd from Sichuan Hebang Biotechnology Corporation Limited for approximately CNY 150 million.
Chinese graduates hold off career dreams, take temporary government jobs
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1J8HD Aktie
  4. Nachrichten Sichuan Hebang Biotechnology Corporation Limited
  5. Andere Sprachen